ArticleExpert opinion on drug metabolism & toxicology2016

Pharmacokinetic and pharmacodynamic evaluation of ibrutinib for the treatment of chronic lymphocytic leukemia: rationale for lower doses.

Prithviraj Bose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.